Viewing nowCombinationDucores 60/2.5 mg
Fimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Korea Nelson Pharmaceutical Co., Ltd.

MFDS item code 202300117 · Approved 2023.01.06
Treatment of essential hypertension not controlled with fimasartan monotherapy
Pimasartan potassium is primarily used for the treatment of essential hypertension. If blood pressure control is insufficient with monotherapy, additional treatment may be necessary. This drug effectively lowers blood pressure and helps reduce the risk of cardiovascular diseases. It plays an important role in stabilizing blood pressure to protect health. Therefore, pimasartan potassium is used to control hypertension.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended to take this medicine at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose of fimasartan. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is necessary for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). For patients with severe renal impairment (creatinine clearance < 30 mL/min), start treatment with the 30 mg fimasartan dose of this medicine. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment. However, this medicine should not be administered to patients with moderate to severe hepatic impairment.
The safety and efficacy of this medicine in pediatric and adolescent patients aged 18 years or younger have not been established.
This drug can cause severe harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Patients with an allergy to the main ingredient or similar components, pregnant or breastfeeding women, dialysis patients, patients with moderate to severe hepatic impairment, biliary obstruction, and certain diabetic patients should not use this drug. Patients with low blood volume or sodium, renal impairment, renovascular hypertension, heart valve disease, severe hypotension, and the elderly should exercise special caution when using this drug. Side effects such as dizziness, headache, edema, urination disorders, insomnia, and flushing may occur while taking this drug, and serious adverse reactions may occur infrequently, so patients should immediately consult a doctor if symptoms are severe. Since this drug lowers blood pressure, patients with hypotension or electrolyte imbalances should correct their condition before taking it, and regularly check blood pressure and electrolyte levels during use. Moreover, since this drug poses a risk of hyperkalemia, it is important to regularly monitor potassium levels in the blood. Interactions may occur when taken with other antihypertensives, diuretics, potassium-sparing diuretics, potassium supplements, certain antibiotics, pain relievers, etc., so patients must inform their healthcare providers of any medications they are taking. Pregnant or breastfeeding women should consult a doctor before taking this drug, as it may affect the fetus or newborn, and discontinue use or breastfeeding if necessary. This drug has not been proven safe and effective for children under 18 years of age, so its use is not recommended. In case of overdose, hypotension, palpitations, and in severe cases, shock may occur. Therefore, patients should adhere to the prescribed dosage and visit a medical institution immediately if any unusual symptoms arise. Finally, this drug should be kept out of reach of children, not transferred to another container, and care should be taken to maintain quality during storage.
Not everyone experiences these, and they can vary from person to person.
This drug may be sensitive to light, so it should be stored in a container that blocks light. Additionally, it is recommended to store the drug at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the drug's efficacy and safety.
Yellow, rounded square film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Korea Nelson Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Ajou Pharmaceuticals Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Kips Biopharma Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Bionex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.